Marrone Bio Innovations

Marrone Bio Innovations, Inc., a biopesticide company, engages in the discovery, development, and marketing of natural products for weed, pest, and plant disease management. Its products include Regalia, a product that protects food and ornamental crops from fungal and bacterial diseases; GreenMatch EX, a postemergence herbicide for burndown weed control for organic growers; and GreenMatch, a burndown herbicide that controls various annual and perennial weeds. The Company also offers insecticides, herbicides, and products for controlling invasive zebra and quagga mussels in waterways. In addition, it finds naturally occurring microorganisms from habitats and develops them into products for controlling insects, weeds, nematodes, and plant diseases.

Company Growth (employees)
Type
Public
HQ
Davis, US
Founded
2006
Size (employees)
97 (est)+13%
Marrone Bio Innovations was founded in 2006 and is headquartered in Davis, US

Key People/Management at Marrone Bio Innovations

Pam Marrone

Pam Marrone

Founder and CEO
Keith Pitts

Keith Pitts

Vice President, Regulatory Affairs

Marrone Bio Innovations Office Locations

Marrone Bio Innovations has an office in Davis
Davis, US (HQ)
2121 Second St.
Davis, US
1540 Drew Ave

Marrone Bio Innovations Financials and Metrics

Marrone Bio Innovations Financials

Marrone Bio Innovations's revenue was reported to be $4.2 b in Q1, 2017
USD

Revenue (Q1, 2017)

4.2 b

Net income (Q1, 2017)

(7.6 b)

EBIT (Q1, 2017)

(5.9 b)

Market capitalization (20-Oct-2017)

27 m

Cash (31-Mar-2017)

1.8 m
Marrone Bio Innovations's current market capitalization is $27 m.
USDFY, 2013Y, 2014FY, 2015FY, 2016

Revenue

14.5 m1.1 m9.8 m14 m

Revenue growth, %

(92%)793%43%

General and administrative expense

18.5 m

Operating expense total

18.5 m
USDQ1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

2.8 m3.6 m2.1 m3.4 m2.5 m2.7 m5 m3.6 m4.2 b

General and administrative expense

6.3 m6 m7.9 m7.4 m5.3 m5.5 m4.5 m3.8 m5.3 b

Operating expense total

6.3 m6 m7.9 m7.4 m5.3 m5.5 m4.5 m3.8 m5.3 b

EBIT

(9.5 m)(9.5 m)(11.3 m)(10.4 m)(8.6 m)(7.5 m)(4.9 m)(5.3 m)(5.9 b)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

24.5 m35.3 m19.8 m9.6 m

Accounts Receivable

6.2 m1.8 m2.3 m3.6 m

Inventories

1.7 m1.3 m1.3 m8.5 m

Current Assets

58.7 m54.7 m36 m26.9 m
USDQ1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

21.3 m57.6 m22.4 m12.2 m27.8 m9.8 m21.2 m16 m1.8 m

Accounts Receivable

7.2 m4.1 m2.2 m3 m1.4 m4.7 m4.5 m2.1 m8.1 m

Inventories

12.8 m12.5 m11.8 m10.6 m9.8 m8.6 m8 m8.4 m8.1 m

Current Assets

47 m80.1 m41.1 m30.2 m43.4 m28.1 m37.8 m30.6 m24.4 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.5 m)(16.2 m)(43.7 b)(31.1 m)

Depreciation and Amortization

976 k2.2 m

Accounts Receivable

(3.4 m)1.8 m(1.2 m)

Inventories

(6.8 m)1.3 m582 k
USDQ1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(10.2 m)(10.4 m)(11.9 m)(11 m)(9.8 m)(9.3 m)(6.8 m)(7.2 m)(7.6 b)

Accounts Receivable

7.2 m4.1 m2.2 m3 m1.4 m4.7 m4.5 m2.1 m8.1 m

Accounts Payable

8.6 m5.2 m4.1 m3.2 m1 m2.6 m2.2 m2.2 m3 m
USDY, 2017

Revenue/Employee

45.4 m

Financial Leverage

-1.2 x
Show all financial metrics

Marrone Bio Innovations Market Value History

Traffic Overview of Marrone Bio Innovations

Marrone Bio Innovations Online and Social Media Presence

Marrone Bio Innovations Company Life and Culture

You may also be interested in